Globally, 850 million patients with liver fibrosis are still facing the long-standing dilemma of “no effective drugs available”. The ineffectiveness of single drugs and the complex pathogenesis have ...
The study shows that this drug pair works far better together than either agent alone, offering a realistic and potentially fast path toward a new antifibrotic therapy. Liver fibrosis is a silent yet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results